Biotech - Press Releases

Date	Title	Company
20-May-2020	Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial	Minoryx Therapeutics
20-May-2020	BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines	The Sabin Vaccine Institute (Sabin)
20-May-2020	Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing	Ori Biotech
20-May-2020	Leica Microsystems Donate an Advanced Microscopy System to Charité’s Institute of Virology to Progress Covid-19 Research	Leica Microsystems
20-May-2020	Why research on ticks could offer potential COVID-19 breakthrough	ILC Therapeutics
20-May-2020	European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease	Takeda Pharmaceutical Company Limited
20-May-2020	ASLAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	ASLAN Pharmaceuticals
20-May-2020	4D Pharma: successful completion of immuno-oncology study safety phase	4D pharma plc
20-May-2020	New COVID-19 Antibody Testing Partnership Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK	Open Orphan plc
20-May-2020	HUMMINGBIRD BIOSCIENCE CLOSES US$25 MILLION INVESTMENT WITH SERIES B EXTENSION	Hummingbird Bioscience
20-May-2020	Senzer to create targeted anti-viral treatments for COVID-19 Launch of Critical Care Division	Senzer Pharmaceuticals
20-May-2020	GILEAD AND KITE CONTINUE TO ADVANCE NEXT GENERATION CANCER THERAPIES AT 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING	Gilead Sciences, Inc.
20-May-2020	Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020	Merck
20-May-2020	Nivolumab plus ipilimumab with chemotherapy shows improved overall survival vs. chemotherapy alone in first-line metastatic nonsmall cell lung cancer in a phase 3 trial	Bristol Myers Squibb
20-May-2020	Orgenesis announces cell-based vaccine platform targeting COVID-19 and other existing and emerging viral diseases	Orgenesis
20-May-2020	IDT broadens capacity and customer support of COVID-19 products with new manufacturing facility	Integrated DNA Technologies, Inc. (IDT)
20-May-2020	Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program	Sanofi
20-May-2020	Danish Team of Researchers to Test Treatment of Critically Ill Patients Suffering from COVID-19	BioPorto
20-May-2020	Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings	Jazz Pharmaceuticals plc
20-May-2020	2020 ASCO Annual Meeting Publishes Three New Abstracts Based on Real-World Data Generated from Belong.Life’s Patient Engagement Network	Belong.Life